WHO ICTRP trial
A Phase II, Open-label Study of INNO-206 in Patients with Recurrent Extensive…
EUCTR2006-005514-12-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-005514-12-DE |
|---|---|
| Public title | A Phase II, Open-label Study of INNO-206 in Patients with Recurrent Extensive Small Cell Lung Cancer after First-line Platinum-based Therapy |
| Scientific title | A Phase II, Open-label Study of INNO-206 in Patients with Recurrent Extensive Small Cell Lung Cancer after First-line Platinum-based Therapy |
| Primary sponsor | INNOVIVE Pharmaceuticals |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Czech Republic;Germany |
| Conditions | Recurrent extensive small cell lung cancer after first-line platinum-based therapy. MedDRA version: 9.1 Level: LLT Classification code 10041067 Term: Small cell lung cancer |
| Interventions | Product Name: INNO-206 Product Code: INNO-206 Pharmaceutical Form: Powder for infusion* INN or Proposed INN: INNO-206 Current Sponsor code: INNO-206 Other descriptive name: DOXO-EMCH Concentration unit: mg milligram(s) Concentration type… |
| Registration date | May 15, 2007 |
| Target size | 40 |
| Secondary IDs | INNO-206-P2 Amendment 3 - Germany |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: